🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $HLT and executed a BUY strategy, securing a +1.48% net profit.

UPGRADE TO SEE LIVE SIGNALS

$RCUS

Arcus Biosciences, Inc.

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 05, 2026 🌙 Close🌐 Website🏛️ NYSE📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP1.49%
MAX GAP RECORD13.18%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.8%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat,… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR RCUS

AI REPORT Jun 02

Deep Dive into GOTU: Earnings Gap Anticipation and Market Impact

AnalysisText about the earnings gap anticipation for $GOTU, including its impact on stock performance and market trends. The…
AI MARKET SCANNING